title: Heparin-induced thrombocytopenia: what clinicians need to know.
authors.affiliation: Level 2, Pitney Building, St George Hospital, Belgrave St., Kogarah, NSW 2217, Australia. beng.chong@unsw.edu.au
authors.forename: Beng H
authors.initials: BH
authors.lastname: Chong
authors.forename: Arend
authors.initials: A
authors.lastname: Isaacs
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use; D001120:Arginine / Q000031:analogs & derivatives; D001323:Autoantibodies / Q000097:blood; D002809:Chondroitin Sulfates / Q000627:therapeutic use; D003871:Dermatan Sulfate / Q000627:therapeutic use; D016903:Drug Monitoring; D000077425:Fondaparinux; D006493:Heparin / Q000009:adverse effects*; D006497:Heparan Sulfate / Q000627:therapeutic use; D006629:Hirudins; D006801:Humans; D010446:Peptide Fragments / Q000627:therapeutic use; D010875:Pipecolic Acids / Q000627:therapeutic use; D010976:Platelet Count; D010978:Platelet Factor 4 / Q000276:immunology; D011134:Polysaccharides / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000627:therapeutic use; D013449:Sulfonamides; D013921:Thrombocytopenia / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D013927:Thrombosis / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D014859:Warfarin / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D001120:Arginine; D001323:Autoantibodies; D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D000077425:Fondaparinux; D006493:Heparin; D006497:Heparan Sulfate; D006629:Hirudins; D010446:Peptide Fragments; D010875:Pipecolic Acids; D010978:Platelet Factor 4; D011134:Polysaccharides; D011994:Recombinant Proteins; D013449:Sulfonamides; D014859:Warfarin; C035838:danaparoid; C031942:argatroban; C074619:bivalirudin; C083544:lepirudin